KRUS:NASDAQKura Sushi USA, Inc. Analysis
Data as of 2026-05-25 - not real-time
$54.28
Latest Price
8/10Risk
Risk Level: High
Executive Summary
KRUS is trading at $54.28, just above its 20‑day SMA of $53.92 but well below the 50‑day ($58.57) and 200‑day ($63.12) averages, indicating short‑term momentum yet a longer‑term bearish bias. The price sits near the calculated support of $47.82 and faces resistance around $58.66, while the RSI of 47 suggests neutral pressure and the MACD histogram’s positive 0.43 points to a fleeting bullish signal. However, volatility is extreme at 55% over the past 30 days and a beta above 1.1 signals heightened sensitivity to market swings, reinforced by a Fear & Greed Index reading of “Extreme Greed.”
Fundamentally, the company posted 23% revenue growth but continues to operate with thin gross margins (16%) and negative operating and profit margins, resulting in a trailing EPS of –$0.15 and a forward EPS of $0.28. Cash flow is strained, with $48 M of cash offset by $203 M of debt (debt‑to‑equity 88.8%) and negative free cash flow, while the DCF fair value of $33.74 implies the market price is roughly 47% above intrinsic value. Analyst consensus remains a “Buy” with a median target near $80, buoyed by a high‑profile Trump investment that sparked a short‑term rally, but the underlying financial weakness and overvaluation raise concerns for longer horizons.
Fundamentally, the company posted 23% revenue growth but continues to operate with thin gross margins (16%) and negative operating and profit margins, resulting in a trailing EPS of –$0.15 and a forward EPS of $0.28. Cash flow is strained, with $48 M of cash offset by $203 M of debt (debt‑to‑equity 88.8%) and negative free cash flow, while the DCF fair value of $33.74 implies the market price is roughly 47% above intrinsic value. Analyst consensus remains a “Buy” with a median target near $80, buoyed by a high‑profile Trump investment that sparked a short‑term rally, but the underlying financial weakness and overvaluation raise concerns for longer horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near short‑term support with modest bullish MACD signal
- increased trading volume and Trump‑related news catalyst
- high volatility and beta indicating rapid price swings
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- strong revenue growth but persistent negative margins
- elevated debt load and negative free cash flow
- valuation gap between market price and DCF fair value
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- overvaluation relative to intrinsic DCF estimate
- structural profitability challenges and high leverage
- consumer‑cyclical exposure to economic downturns
Key Metrics & Analysis
Financial Health
Revenue Growth23.30%
Profit Margin-0.63%
P/E Ratio192.0
ROE-0.85%
ROA-0.42%
Debt/Equity88.79
P/B Ratio2.9
Op. Cash Flow$24.2M
Free Cash Flow$-36375124
Technical Analysis
TrendBearish
RSI47.4
Support$47.82
Resistance$58.66
MA 20$53.92
MA 50$58.57
MA 200$63.12
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61
Valuation
Fair Value$33.74
Target Price$79.90
Upside/Downside47.20%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.16
Volatility55.43%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.